Ladenburg Thalmann Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $275K | Sell |
11,498
-270
| -2% | -$6.46K | ﹤0.01% | 2268 |
|
|
2019
Q3 | $315K | Sell |
11,768
-3,132
| -21% | -$83.8K | ﹤0.01% | 2132 |
|
|
2019
Q2 | $403K | Buy |
14,900
+6,710
| +82% | +$181K | ﹤0.01% | 1921 |
|
|
2019
Q1 | $285K | Buy |
8,190
+538
| +7% | +$18.7K | ﹤0.01% | 2134 |
|
|
2018
Q4 | $150K | Sell |
7,652
-458
| -6% | -$8.98K | ﹤0.01% | 2455 |
|
|
2018
Q3 | $216K | Buy |
8,110
+586
| +8% | +$15.6K | ﹤0.01% | 2257 |
|
|
2018
Q2 | $245K | Hold |
7,524
| – | – | ﹤0.01% | 2084 |
|
|
2018
Q1 | $245K | Buy |
7,524
+210
| +3% | +$6.84K | ﹤0.01% | 2084 |
|
|
2017
Q4 | $356K | Buy |
7,314
+300
| +4% | +$14.6K | ﹤0.01% | 1783 |
|
|
2017
Q3 | $379K | Buy |
7,014
+460
| +7% | +$24.9K | ﹤0.01% | 1646 |
|
|
2017
Q2 | $368K | Buy |
6,554
+11
| +0.2% | +$618 | ﹤0.01% | 1589 |
|
|
2017
Q1 | $256K | Sell |
6,543
-605
| -8% | -$23.7K | ﹤0.01% | 1740 |
|
|
2016
Q4 | $161K | Sell |
7,148
-1,097
| -13% | -$24.7K | ﹤0.01% | 1977 |
|
|
2016
Q3 | $187K | Buy |
8,245
+144
| +2% | +$3.27K | ﹤0.01% | 1804 |
|
|
2016
Q2 | $191K | Buy |
8,101
+944
| +13% | +$22.3K | ﹤0.01% | 1712 |
|
|
2016
Q1 | $146K | Sell |
7,157
-75
| -1% | -$1.53K | ﹤0.01% | 1822 |
|
|
2015
Q4 | $372K | Buy |
7,232
+959
| +15% | +$49.3K | 0.01% | 1188 |
|
|
2015
Q3 | $267K | Buy |
6,273
+2,875
| +85% | +$122K | 0.01% | 1290 |
|
|
2015
Q2 | $154K | Buy |
3,398
+1,350
| +66% | +$61.2K | ﹤0.01% | 1799 |
|
|
2015
Q1 | $78K | Buy |
2,048
+48
| +2% | +$1.83K | ﹤0.01% | 2251 |
|
|
2014
Q4 | $57K | Buy |
+2,000
| New | +$57K | ﹤0.01% | 2287 |
|